| Literature DB >> 15752746 |
Keqiang Fan1, Liang Ma, Xiaofeng Han, Huanhuan Liang, Ping Wei, Ying Liu, Luhua Lai.
Abstract
The 3C-like proteinase of severe acute respiratory syndrome coronavirus (SARS) has been proposed to be a key target for structural based drug design against SARS. We have designed and synthesized 34 peptide substrates and determined their hydrolysis activities. The conserved core sequence of the native cleavage site is optimized for high hydrolysis activity. Residues at position P4, P3, and P3' are critical for substrate recognition and binding, and increment of beta-sheet conformation tendency is also helpful. A comparative molecular field analysis (CoMFA) model was constructed. Based on the mutation data and CoMFA model, a multiply mutated octapeptide S24 was designed for higher activity. The experimentally determined hydrolysis activity of S24 is the highest in all designed substrates and is close to that predicted by CoMFA. These results offer helpful information for the research on the mechanism of substrate recognition of coronavirus 3C-like proteinase.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15752746 PMCID: PMC7092912 DOI: 10.1016/j.bbrc.2005.02.061
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575
Enzyme cleavage activities of mutated substrate peptides
| Substrate | Sequence | Apparent | ( |
|---|---|---|---|
| S12 | SAVLQ ↓ SGF-CONH2 | 2.13 ± 0.20 | 1.00 |
| P5L | 8.32 ± 0.25 | 3.90 | |
| P5T | 7.80 ± 0.24 | 3.66 | |
| P5V | 7.66 ± 0.30 | 3.59 | |
| P5A | 7.10 ± 0.24 | 3.33 | |
| P4L | S | 0.33 ± 0.04 | 0.15 |
| P4T | S | 3.14 ± 0.12 | 1.47 |
| P4V | S | 5.21 ± 1.27 | 2.44 |
| P3L | SA | 1.85 ± 0.06 | 0.87 |
| P3T | SA | 2.53 ± 0.54 | 1.19 |
| P3A | SA | 0.40 ± 0.03 | 0.19 |
| P3K | SA | 5.72 ± 0.45 | 2.68 |
| P1′A | SAVLQ ↓ | 4.36 ± 0.19 | 2.04 |
| P1′G | SAVLQ ↓ | 1.76 ± 0.09 | 0.83 |
| P1′L | SAVLQ ↓ | ND | |
| S12 | SAVLQ ↓ SGF-CONH2 | 12.68 ± 0.60* | 1.000 |
| P2M | SAV | 2.54 ± 0.07* | 0.208 |
| P2F | SAV | 0.58 ± 0.10* | 0.046 |
| P2I | SAV | 0.080 ± 0.011* | 0.0063 |
| P2V | SAV | 0.070 ± 0.009* | 0.0056 |
| P2A | SAV | 0.058 ± 0.008* | 0.0046 |
| P2R | SAV | ND | |
| P1N | SAVL | ND | |
| P1E | SAVL | ND | |
| P1K | SAVL | ND | |
| S21 | 8.48 ± 1.32 | 3.98 | |
| S22 | 5.58 ± 0.21 | 2.62 | |
| S23 | 5.18 ± 0.74 | 2.43 | |
| S24 | 9.18 ± 0.25 | 4.31 |
Mutated residues are underlined. Cleavage sites are indicated by ↓.
The concentration of SARS 3C-like proteinase is 5.41 μM for substrates without any label and that for substrates labeled with asterisk is 27.05 μM.
Not detectable in HPLC-based peptide cleavage assay.
Fig. 1The superimposed 22 substrate structures and the contour plot of the CoMFA model. This result indicates that increasing positive charge at position P3 is favored (blue), and large hydrophobic residue at position P2 is favored (green), which is compatible with the crystal structure. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this paper.)
Enzyme cleavage activities of truncated substrate peptides
| Substrate | Sequence | Apparent | ( |
|---|---|---|---|
| S12 | SAVLQ ↓ SGF-CONH2 | 7.85 ± 0.30 | 1.00 |
| S13 | AVLQ ↓ SG-CONH2 | 1.19 ± 0.03 | 0.152 |
| S14 | VLQ ↓ SG-CONH2 | 0.148 ± 0.006 | 0.0189 |
| S15 | AVLQ ↓ S-CONH2 | 1.01 ± 0.02 | 0.129 |
| S16 | VLQ ↓ S-CONH2 | 0.131 ± 0.006 | 0.0167 |
| S17 | AVLQ ↓ SGF-CONH2 | 5.99 ± 0.08 | 0.763 |
| S18 | LQ ↓ SG-CONH2 | 0.013 ± 0.004 | 0.0017 |
Cleavage sites are indicated by ↓.
The concentration of SARS 3C-like proteinase is 7.41 μM.